Literature DB >> 20200247

Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.

Judith M Gottwein1, Troels K H Scheel, Benoit Callendret, Yi-Ping Li, Heather B Eccleston, Ronald E Engle, Sugantha Govindarajan, William Satterfield, Robert H Purcell, Christopher M Walker, Jens Bukh.   

Abstract

Previously, RNA transcripts of cDNA clones of hepatitis C virus (HCV) genotypes 1a (strains H77, HCV-1, and HC-TN), 1b (HC-J4, Con1, and HCV-N), and 2a (HC-J6 and JFH1) were found to be infectious in chimpanzees. However, only JFH1 was infectious in human hepatoma Huh7 cells. We performed genetic analysis of HCV genotype 3a (strain S52) and 4a (strain ED43) prototype strains and generated full-length consensus cDNA clones (pS52 and pED43). Transfection of Huh7.5 cells with RNA transcripts of these clones did not yield cells expressing HCV Core. However, intrahepatic transfection of chimpanzees resulted in robust infection with peak HCV RNA titers of approximately 5.5 log(10) international units (IU)/ml. Genomic consensus sequences recovered from serum at the times of peak viral titers were identical to the sequences of the parental plasmids. Both chimpanzees developed acute hepatitis with elevated liver enzymes and significant necroinflammatory liver changes coinciding with detection of gamma interferon-secreting, intrahepatic T cells. However, the onset and broadness of intrahepatic T-cell responses varied greatly in the two animals, with an early (week 4) multispecific response in the ED43-infected animal (3 weeks before the first evidence of viral control) and a late (week 11) response with limited breadth in the S52-infected animal (without evidence of viral control). Autologous serum neutralizing antibodies were not detected during the acute infection in either animal. Both animals became persistently infected. In conclusion, we generated fully functional infectious cDNA clones of HCV genotypes 3a and 4a. Proof of functionality of all genes might further the development of recombinant cell culture systems for these important genotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200247      PMCID: PMC2863810          DOI: 10.1128/JVI.02667-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

1.  Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

Authors:  N H Grüner; T J Gerlach; M C Jung; H M Diepolder; C A Schirren; W W Schraut; R Hoffmann; R Zachoval; T Santantonio; M Cucchiarini; A Cerny; G R Pape
Journal:  J Infect Dis       Date:  2000-05-05       Impact factor: 5.226

2.  Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

Authors:  L Rubbia-Brandt; R Quadri; K Abid; E Giostra; P J Malé; G Mentha; L Spahr; J P Zarski; B Borisch; A Hadengue; F Negro
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

3.  The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the liver in acute hepatitis C virus infection.

Authors:  Eui-Cheol Shin; Stefania Capone; Riccardo Cortese; Stefano Colloca; Alfredo Nicosia; Antonella Folgori; Barbara Rehermann
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

Review 4.  Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.

Authors:  Judith M Gottwein; Jens Bukh
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

5.  Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.

Authors:  Takanobu Kato; Youkyung Choi; Gamal Elmowalid; Ronda K Sapp; Heidi Barth; Akihiro Furusaka; Shunji Mishiro; Takaji Wakita; Krzysztof Krawczynski; T Jake Liang
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

6.  Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly.

Authors:  Vlastimil Jirasko; Roland Montserret; Nicole Appel; Anne Janvier; Leah Eustachi; Christiane Brohm; Eike Steinmann; Thomas Pietschmann; Francois Penin; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

7.  Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice.

Authors:  Takashi Kimura; Michio Imamura; Nobuhiko Hiraga; Tsuyoshi Hatakeyama; Daiki Miki; Chiemi Noguchi; Nami Mori; Masataka Tsuge; Shoichi Takahashi; Yoshifumi Fujimoto; Eiji Iwao; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Keiko Arataki; Chise Tateno; Katsutoshi Yoshizato; Takaji Wakita; Toru Okamoto; Yoshiharu Matsuura; Kazuaki Chayama
Journal:  J Gen Virol       Date:  2008-09       Impact factor: 3.891

8.  Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.

Authors:  Jens Bukh; Robert Thimme; Jean-Christophe Meunier; Kristina Faulk; Hans Christian Spangenberg; Kyong-Mi Chang; William Satterfield; Francis V Chisari; Robert H Purcell
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly.

Authors:  Yinghong Ma; Jeremy Yates; Yuqiong Liang; Stanley M Lemon; MinKyung Yi
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

View more
  65 in total

1.  Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Steven K H Foung; Mansun Law; Jens Bukh
Journal:  Hepatology       Date:  2016-08-09       Impact factor: 17.425

Review 2.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

3.  Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.

Authors:  Mohsan Saeed; Troels K H Scheel; Judith M Gottwein; Svetlana Marukian; Lynn B Dustin; Jens Bukh; Charles M Rice
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

4.  Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.

Authors:  Yi-Ping Li; Santseharay Ramirez; Sanne B Jensen; Robert H Purcell; Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

5.  Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.

Authors:  Sanne B Jensen; Stéphanie B N Serre; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

6.  Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.

Authors:  Zhihua Li; Yadong Li; Yanwei Bi; Hui Zhang; Yufeng Yao; Qihan Li; Wei Cun; Shaozhong Dong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.

Authors:  Jannick Prentoe; Tanja B Jensen; Philip Meuleman; Stéphanie B N Serre; Troels K H Scheel; Geert Leroux-Roels; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

8.  Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.

Authors:  Jean-Christophe Meunier; Judith M Gottwein; Michael Houghton; Rodney S Russell; Suzanne U Emerson; Jens Bukh; Robert H Purcell
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

9.  Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.

Authors:  Zhenyong Keck; Wenyan Wang; Yong Wang; Patrick Lau; Thomas H R Carlsen; Jannick Prentoe; Jinming Xia; Arvind H Patel; Jens Bukh; Steven K H Foung
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.

Authors:  Rodrigo Velázquez-Moctezuma; Andrea Galli; Mansun Law; Jens Bukh; Jannick Prentoe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.